OPG Power Ventures posts marginal decline in revenue
OPG Power Ventures, the developer and operator of power generation plants in India, saw revenue slip in the six months ended September 30th 2012.
OPG Power Ventures, the developer and operator of power generation plants in India, saw revenue slip in the six months ended September 30th 2012.
Revenue fell 5.3% to £17.8m from £18.8m year-on-year excluding legacy assets no longer consolidated from November 2011.
The group pointed out that the 17% depreciation in the average Indian rupee/pound sterling exchange rate since the comparable period of the previous year masked an underlying increase in rupee revenues of 11%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Earnings before interest, tax, depreciation and amortisation (EBITDA) declined by 7.6% to £4.65m while the EBITDA margin stood at 26%, 1% less than the previous year's margin.
Cash and cash equivalents of £22.5m were reported as well as 31% of gearing following project expenditure.
Commenting on the results, Mr M C Gupta, Chairman of OPG Ppwer Ventures said: "The group's flexible business model continues to produce superior returns and OPG's roll out of new plants is on schedule.
"Once again management have been able to demonstrate the effectiveness of the business model by successfully adapting to changing circumstances in the industry such as rising input prices and changes in tariff structures.
"The growing power demand in India combined with our roll out and in particular measures now being instituted to improve the financial health of the state utilities makes us confident that OPG will continue to build superior shareholder value."
The group's share price was down 1.92% to 51p at 11:48 on Thursday morning.
MF
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published